A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Personalis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 16,900 shares of PSNL stock, worth $101,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,900
Previous 27,500 38.55%
Holding current value
$101,231
Previous $32,000 181.25%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $6.34 $381,098 - $2.03 Million
-320,251 Reduced 90.15%
34,990 $188,000
Q2 2024

Aug 14, 2024

SELL
$1.17 - $1.65 $178,186 - $251,288
-152,296 Reduced 30.01%
355,241 $415,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $86,700 - $165,108
75,392 Added 17.45%
507,537 $756,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $288,150 - $728,121
309,839 Added 253.33%
432,145 $907,000
Q3 2023

Nov 14, 2023

SELL
$1.19 - $2.36 $50,827 - $100,800
-42,712 Reduced 25.88%
122,306 $147,000
Q2 2023

Aug 14, 2023

SELL
$1.8 - $3.19 $96,863 - $171,663
-53,813 Reduced 24.59%
165,018 $310,000
Q1 2023

May 15, 2023

SELL
$2.01 - $4.17 $34,831 - $72,261
-17,329 Reduced 7.34%
218,831 $603,000
Q4 2022

Feb 14, 2023

BUY
$1.78 - $3.64 $49,742 - $101,719
27,945 Added 13.42%
236,160 $467,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $734,854 - $1.35 Million
-254,275 Reduced 54.98%
208,215 $618,000
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $943,097 - $2.53 Million
288,409 Added 165.68%
462,490 $1.6 Million
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $147,911 - $279,779
19,565 Added 12.66%
174,081 $1.43 Million
Q4 2021

Feb 14, 2022

SELL
$12.24 - $21.25 $962,455 - $1.67 Million
-78,632 Reduced 33.73%
154,516 $2.2 Million
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $334,484 - $522,068
-20,041 Reduced 7.92%
233,148 $4.49 Million
Q2 2021

Aug 16, 2021

SELL
$18.15 - $27.75 $1.69 Million - $2.59 Million
-93,286 Reduced 26.92%
253,189 $6.41 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $4.31 Million - $10.6 Million
208,296 Added 150.74%
346,475 $8.53 Million
Q4 2020

Feb 16, 2021

SELL
$21.84 - $44.0 $2.4 Million - $4.84 Million
-109,893 Reduced 44.3%
138,179 $5.06 Million
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $2.47 Million - $4.38 Million
181,431 Added 272.25%
248,072 $5.38 Million
Q2 2020

Aug 14, 2020

SELL
$7.65 - $14.11 $211,208 - $389,562
-27,609 Reduced 29.29%
66,641 $865,000
Q1 2020

May 15, 2020

SELL
$4.75 - $12.41 $36,940 - $96,512
-7,777 Reduced 7.62%
94,250 $760,000
Q4 2019

Feb 14, 2020

SELL
$8.73 - $12.95 $116,205 - $172,377
-13,311 Reduced 11.54%
102,027 $1.11 Million
Q3 2019

Nov 14, 2019

SELL
$14.16 - $25.34 $66,042 - $118,185
-4,664 Reduced 3.89%
115,338 $1.69 Million
Q2 2019

Aug 14, 2019

BUY
$27.0 - $30.25 $3.24 Million - $3.63 Million
120,002 New
120,002 $3.26 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $275M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.